Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Cingulate Inc. is a biopharmaceutical company developing innovative drugs using its proprietary Precision Timed Release platform to improve treatment of conditions like ADHD and anxiety. Its pipeline includes next-generation stimulant medications and non-stimulant therapies designed for once-daily dosing, faster onset, and better tolerability. The company focuses on clinical development, strategic partnerships, licensing, and leveraging its intellectual property to address unmet medical needs in large markets.
This description was generated via AI from an annual report. Updated about 1 year ago.